NASDAQ STOCKHOLM WELCOMES SPRINT BIOSCIENCE TO FIRST NORTH

Stockholm, November 7, 2014 — Nasdaq (Nasdaq: NDAQ) announces that the trading in Sprint Bioscience AB (shortname: SPRINT) shares commenced today on First North at Nasdaq Stockholm. Sprint Bioscience belongs to the Healthcare sector and is the 36th company to be admitted to trading on First North’s Nordic markets (Stockholm, Helsinki, Copenhagen and Iceland) in 2014.

Sprint Bioscience is a Swedish biotechnology firm that works to deliver the foundation for new cancer drugs to the pharmaceutical industry. The company’s mission is to speed up development of novel therapies exploiting cancer metabolism and lipid signaling. For more information, visit www.sprintbioscience.com.

“With today’s First North listing I’m pleased that we can continue to develop our strategy and grow our business”, said Anders Åberg, CEO, Sprint Bioscience.

“Nasdaq welcomes Sprint Bioscience to First North and to our family of listed companies,” said Adam Kostyal, Senior Vice President and head of European listings at Nasdaq. “Sprint Bioscience will make an interesting addition to our vibrant healthcare sector, and we look forward to supporting the company in its endavour as a publically traded company.”

Sprint Bioscience has appointed Redeye AB as Certified Adviser.

About First North

First North is regulated as a multilateral trading facility, operated by the different exchanges within Nasdaq Nordic. It does not have the legal status as an EU-regulated market. Companies at First North are subject to the rules of First North and not the legal requirements for admission to trading on a regulated market. The risk in such an investment may be higher than on the main market.

About Nasdaq

Nasdaq (Nasdaq: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today’s global capital markets. As the creator of the world’s first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,500 listed companies with a market value of over $8.8 trillion and more than 10,000 corporate clients. To learn more, visit www.nasdaqomx.com.

Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland, Nasdaq Riga, Nasdaq Stockholm, Nasdaq Tallinn, Nasdaq Vilnius, Nasdaq Clearing and Nasdaq Broker Services are respectively brand names for the regulated markets of Nasdaq OMX Copenhagen A/S, Nasdaq OMX Helsinki Ltd., Nasdaq OMX Iceland hf., Nasdaq OMX Riga, AS, Nasdaq OMX Stockholm AB, Nasdaq OMX Tallinn AS, AB Nasdaq OMX Vilnius, Nasdaq OMX Clearing AB, Nasdaq OMX Broker Services AB. Nasdaq Nordic represents the common offering by Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland and Nasdaq Stockholm. Nasdaq Baltic represents the common offering by Nasdaq Tallinn, Nasdaq Riga and Nasdaq Vilnius.

Cautionary Note Regarding Forward-Looking Statements

The matters described herein contain forward-looking statements that are made under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements about Nasdaq and its products and offerings. We caution that these statements are not guarantees of future performance. Actual results may differ materially from those expressed or implied in the forward-looking statements. Forward-looking statements involve a number of risks, uncertainties or other factors beyond Nasdaq's control. These factors include, but are not limited to factors detailed in Nasdaq's annual report on Form 10-K, and periodic reports filed with the U.S. Securities and Exchange Commission. We undertake no obligation to release any revisions to any forward-looking statements.